Revance Therapeutics, Inc. (48) | Business Operations (7)

Browse by Subcategory

Recent Contracts

Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated March 14, 2017 between Revance Therapeutics, Inc. and Ajinomoto Althea, Inc (Filed With SEC on February 28, 2022)
Commercial Supply Agreement, effective as of April 6, 2021, by and between Revance Therapeutics, Inc. and Lyophilization Services of New England, Inc (Filed With SEC on August 5, 2021)
First Amendment to Exclusive Distribution Agreement (Filed With SEC on November 9, 2020)
Form of Voting Agreement by and between Revance Therapeutics, Inc. and each of the parties named in each agreement therein (Filed With SEC on June 10, 2020)
Amendment #1 to the Collaboration and License Agreement dated August 22, 2019 between Revance Therapeutics, Inc. and Mylan Ireland Ltd (Filed With SEC on November 4, 2019)
Amendment No. 1 to the Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated December 18, 2020 between Revance Therapeutics, Inc. and Ajinomoto... (Filed With SEC on February 25, 2021)
Exclusive Distribution Agreement, dated January 10, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA (Filed With SEC on February 26, 2020)